San Francisco, CA, United States of America

Robert Kuehl

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 183(Granted Patents)


Location History:

  • East Longmeadow, MA (US) (1989 - 1994)
  • San Francisco, CA (US) (2017 - 2024)

Company Filing History:


Years Active: 1989-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Robert Kuehl

Introduction

Robert Kuehl, an accomplished inventor based in San Francisco, California, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of nine patents to his name, Kuehl's work primarily focuses on heterocyclic compounds and their applications in medicine.

Latest Patents

Among his latest patents, Kuehl has developed specific pharmaceutical formulations of omecamtiv mecarbil, along with methods for their preparation and use. His discoveries in this area have the potential to impact the treatment of cardiovascular diseases significantly.

Career Highlights

Throughout his career, Kuehl has collaborated with notable companies, including Pharmacyclics, Inc. and Amgen Inc., where he honed his skills and furthered his research pursuits in pharmaceuticals. His innovative mind and dedication have led to groundbreaking advancements in medical science.

Collaborations

In addition to his work at prominent organizations, Kuehl has teamed up with esteemed colleagues such as Harisha Atluri and Ching Wah Chong. Together, they have contributed to the expanding knowledge and application of pharmaceutical formulations, focusing on enhancing therapeutic options for various health conditions.

Conclusion

Robert Kuehl stands as a noteworthy figure in the landscape of innovation, particularly in the development of pharmaceutical formulations. His extensive patent portfolio and collaboration with leading companies and talented individuals underscore his influence in the field. The impact of his work continues to drive advancements in drug formulation and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…